Literature DB >> 2820636

The influence of cytomegalovirus carrier status on lymphocyte subsets and natural immunity.

J W Gratama1, M Kardol, A M Naipal, J Slats, A Den Ouden, T Stijnen, J D'Amaro, T H The, J W Bruning.   

Abstract

The influence of the cytomegalovirus (CMV) carrier status on peripheral lymphocyte subsets was studied in 70 healthy individuals. IgG-class antibodies against CMV late antigen were used as markers for the presence of CMV in those individuals. The 39 CMV-seropositive individuals had significantly higher numbers of CD3+ (P = 0.009), CD8+ (P = 0.005) and HNK1+ (P = 0.002) cells than the 31 CMV-seronegative individuals. Two-colour immunofluorescence studies revealed that the HNK1+ cells coexpressing CD4 or high density CD8 were particularly increased in the number under the influence of CMV, but not the HNK1+ cells coexpressing CD16. Since HNK1 and CD16 are markers associated with natural killer (NK) activity and antibody-dependent cellular cytotoxicity (ADCC), we investigated the influence of the CMV carrier status on those functions. The NK and ADCC functions of peripheral blood mononuclear cells (PBMC), HNK1+ and HNK1- cells were correlated with the percentages of CD16+ cells among those cells. Although CMV-seropositive individuals had significantly less CD16+ cells among their HNK1+ cells than CMV-seronegative individuals (mean and s.d.: 39 and 19%, versus 58 and 11%, P = 0.003), the NK and ADCC functions of the HNK1+ cells were similar in both groups. Also, the CMV carrier status did not influence significantly those functions of PBMC and HNK1- cells. We conclude that the CMV carrier status, i.e. CMV-seropositivity, is associated with a significant increase in the numbers of HNK1+ lymphocytes coexpressing T cell markers. That situation may reflect the continuing interaction between CMV and the immune system of its host.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2820636      PMCID: PMC1542248     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

Review 1.  The cytomegaloviruses: ubiquitous agents with protean clinical manifestations. I.

Authors:  T H Weller
Journal:  N Engl J Med       Date:  1971-07-22       Impact factor: 91.245

2.  Analysis of T lymphocyte subsets in cytomegalovirus mononucleosis.

Authors:  W P Carney; R H Rubin; R A Hoffman; W P Hansen; K Healey; M S Hirsch
Journal:  J Immunol       Date:  1981-06       Impact factor: 5.422

3.  Regeneration of T cell subpopulations after bone marrow transplantation: cytomegalovirus infection and lymphoid subset imbalance.

Authors:  R W Schroff; R P Gale; J L Fahey
Journal:  J Immunol       Date:  1982-11       Impact factor: 5.422

4.  A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1).

Authors:  T Abo; C M Balch
Journal:  J Immunol       Date:  1981-09       Impact factor: 5.422

5.  Acute cytomegalovirus infection and the host immune response. I. Development and maintenance of cytomegalovirus (CMV) induced in vitro lymphocyte reactivity and its relationship to the production of CMV antibodies.

Authors:  C H ten Napel; T H The
Journal:  Clin Exp Immunol       Date:  1980-02       Impact factor: 4.330

6.  Human renal allograft rejection is predicted by serial determinations of antibody-dependent cellular cytotoxicity.

Authors:  L J Dumble; I M MacDonald; P Kincaid-Smith
Journal:  Transplantation       Date:  1980       Impact factor: 4.939

7.  Immune response to herpesvirus antigens in adults with acute cytomegaloviral mononucleosis.

Authors:  M J Levin; C R Rinaldo; P L Leary; J A Zaia; M S Hirsch
Journal:  J Infect Dis       Date:  1979-12       Impact factor: 5.226

8.  Characterization of HNK-1+ (Leu-7) human lymphocytes. I. Two distinct phenotypes of human NK cells with different cytotoxic capability.

Authors:  T Abo; M D Cooper; C M Balch
Journal:  J Immunol       Date:  1982-10       Impact factor: 5.422

9.  Suppressor cell function of human granular lymphocytes identified by the HNK-1 (Leu 7) monoclonal antibody.

Authors:  A B Tilden; T Abo; C M Balch
Journal:  J Immunol       Date:  1983-03       Impact factor: 5.422

10.  Postnatal expansion of the natural killer and keller cell population in humans identified by the monoclonal HNK-1 antibody.

Authors:  T Abo; M D Cooper; C M Balch
Journal:  J Exp Med       Date:  1982-01-01       Impact factor: 14.307

View more
  15 in total

1.  Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8(+) T lymphocytes in healthy seropositive donors.

Authors:  G M Gillespie; M R Wills; V Appay; C O'Callaghan; M Murphy; N Smith; P Sissons; S Rowland-Jones; J I Bell; P A Moss
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  CD8 lymphocytosis in primary cytomegalovirus (CMV) infection of allograft recipients: expansion of an uncommon CD8+ CD57- subset and its progressive replacement by CD8+ CD57+ T cells.

Authors:  M Labalette; F Salez; F R Pruvot; C Noel; J P Dessaint
Journal:  Clin Exp Immunol       Date:  1994-03       Impact factor: 4.330

3.  Abnormal T cell receptor V gene usage in myasthenia gravis: prevalence and characterization of expanded T cell populations.

Authors:  B Y Xu; R Giscombe; A Söderlund; M Troye-Blomberg; R Pirskanen; A K Lefvert
Journal:  Clin Exp Immunol       Date:  1998-09       Impact factor: 4.330

4.  Changes in natural killer cells, the CD57CD8 subset, and related cytokines in healthy aging.

Authors:  S E McNerlan; I M Rea; H D Alexander; T C Morris
Journal:  J Clin Immunol       Date:  1998-01       Impact factor: 8.317

5.  Progressive decrease of CD8high+ CD28+ CD57- cells with ageing.

Authors:  J Merino; M A Martínez-González; M Rubio; S Inogés; A Sánchez-Ibarrola; M L Subirá
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

6.  Phenotypic study of CD4+ and CD8+ lymphocyte subsets in relation to cytomegalovirus carrier status and its correlate with pokeweed mitogen-induced B lymphocyte differentiation.

Authors:  J W Gratama; R A Langelaar; M A Oosterveer; J A van der Linden; A den Ouden-Noordermeer; A M Naipal; J W Visser; G C de Gast; H J Tanke
Journal:  Clin Exp Immunol       Date:  1989-08       Impact factor: 4.330

7.  Immunologic abnormalities related to antigenaemia during HIV-1 infection.

Authors:  P De Paoli; S Battistin; M Crovatto; M L Modolo; A Carbone; U Tirelli; G Santini
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

8.  Emergence of non-major-histocompatibility-complex-restricted lytic CD8+ cells in the blood of nasopharyngeal carcinoma patients.

Authors:  M Lakhdar; H Thameur; M Maalej; F Ben Ayed; A Ladgham
Journal:  Cancer Immunol Immunother       Date:  1993-07       Impact factor: 6.968

9.  Subsets of CD8+, CD57+ cells in normal, healthy individuals: correlations with human cytomegalovirus (HCMV) carrier status, phenotypic and functional analyses.

Authors:  E C Wang; J Taylor-Wiedeman; P Perera; J Fisher; L K Borysiewicz
Journal:  Clin Exp Immunol       Date:  1993-11       Impact factor: 4.330

10.  Expanded T cell populations in patients with Wegener's granulomatosis: characteristics and correlates with disease activity.

Authors:  R Giscombe; S Nityanand; N Lewin; J Grunewald; A K Lefvert
Journal:  J Clin Immunol       Date:  1998-11       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.